Side Effects of Pirbuterol

Nausea, nervousness, and shakiness are a few common side effects of pirbuterol. In most cases, the side effects seen with pirbuterol are minor and don't require medical attention. However, certain problems should be reported to a healthcare provider immediately. Alert your healthcare provider right away if you experience worsening breathing problems, a very fast heart rate, or high blood pressure, among other serious side effects.

An Introduction to Side Effects of Pirbuterol

As with any medicine, there are possible side effects with pirbuterol acetate (Maxair®). However, not everyone who takes the medication will experience side effects. In fact, most people tolerate pirbuterol well. When side effects do occur, in most cases they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
(This article covers many, but not all, of the possible side effects with pirbuterol. Your healthcare provider can discuss a more complete list of pirbuterol side effects with you.)
Pirbuterol inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. Pirbuterol inhalers contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. The manufacturer of pirbuterol is working on a reformulated, CFC-free version, although it is not yet clear when that product will be available to consumers.
7 Easy Tips for Starting Solids

Pirbuterol (Maxair)

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.